NCT03775135

Brief Summary

Up to 20% of the adolescents worldwide are diagnosed with a chronic illness. Although it's known that these young people suffer from a wide range of physical discomfort, in real life they have to cope with much more challenges whether or not caused by their physical situation. Psychiatric disorders (e.g. ASS, ADHD or depression) are more often diagnosed in this population compared to their healthy peers. The causal mechanisms for this higher risk, however, are yet unknown. This project examines three underlying intrapersonal processes possibly having an impact on the evolution of these secondary symptoms. Previous research confirmed the significant impact of having a chronic illness on the development of identity and the association with a higher prevalence of depressive symptoms. Identity formation is a crucial developmental task to transfer from a child to an independent, responsible adult. We believe this developmental task is more at risk for youngsters and young adults suffering from a physical disability, caused by a neuromuscular disease. In this longitudinal research project, we investigate the development of identity in youth with a neuromuscular disease, compared to healthy peers and compared to a group of peers with a non-visible chronical illness. We also evaluate the impact of the degree of physical functioning on those mechanisms. Second, we examine if parental behavior and parental functioning is linked with the formation of identity in a neuromuscular populations. Finally, the impact of identity formation on psychosocial outcomes (e.g. feelings of depression and anxiety, quality of life, …) is measured. By addressing these research questions, this project will add substantially to our knowledge on identity in chronic illness and can inform future prevention and intervention efforts targeting illness adaptation and parental functioning in order to prevent negative psychosocial outcomes and to optimize quality of life.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jan 2019

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 13, 2018

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 13, 2018

Completed
19 days until next milestone

Study Start

First participant enrolled

January 1, 2019

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2020

Completed
Last Updated

December 13, 2018

Status Verified

November 1, 2018

Enrollment Period

1.1 years

First QC Date

November 13, 2018

Last Update Submit

December 12, 2018

Conditions

Keywords

Identity

Outcome Measures

Primary Outcomes (2)

  • Manifestation of identity in 120 patients with neuromuscular diseases

    Identity development will be measured with specific questionnaires

    up to year 1

  • Psychosocial functioning in 120 patients with neuromuscular diseases

    Psychosocial functioning will be measures with specific questionnaires

    up to year 1

Study Arms (1)

Children with neuromuscular diseases

Questionnaires will be administered by children with neuromuscular disease between 12 and 25 years and their parents

Other: Questionnaires

Interventions

Different questionnaires about identity development and psychosocial functioning will be administered

Children with neuromuscular diseases

Eligibility Criteria

Age12 Years - 25 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Children with neuromuscular diseases between 12 and 25 years

You may qualify if:

  • confirmed diagnoses of a neuromuscular disorder;
  • aged 12-25 years at baseline;
  • last neuromuscular consult at our NMRC is 5 or less years ago;
  • able to read and write Dutch;
  • valid contact details available in the clinical database or the hospital information system.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Neuromuscular Diseases

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Nervous System Diseases

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Nathalie Goemans, MD, PhD

    UZ Leuven

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 13, 2018

First Posted

December 13, 2018

Study Start

January 1, 2019

Primary Completion

February 1, 2020

Study Completion

February 1, 2020

Last Updated

December 13, 2018

Record last verified: 2018-11

Data Sharing

IPD Sharing
Will not share